Use access key #2 to skip to page content.
$22.73 2.82 (14.16%)
10/13/2008 4:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating:
***

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

View All Commentary (BMRN)

Recs

3

Avatar bmw201030 (98.32) Submitted: 10/06/06 6:33 PM : Outperform Start Price: $15.97 BMRN Score: 75.63

The Orphan Drug status gives BMRN a virtual monopoly for close to the next decade. It's a wide moat for now, I expect this to outperform the market the next 2-7 years.

Report this Post Replies: 0 | Reply

Featured Broker Partners